Cme Group Inc. (CME) Stock Analysis and Metrics

Cme

NASDAQ: CME

$255.40 ▲ +0.10 (+0.04%)

At close: Jul 27, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap92.16 Bn

P/E21.56

P/S13.61

Div. Yield0.04

Total Debt (Qtr)3.42 Bn

Add ratio to table…

About

CME Group enables clients to trade futures, options, cash, and over the counter products, optimize portfolios, and analyze data. The company provides primary price discovery and referential pricing information through its market data in real time historical and derived formats. It also operates one of the world’s leading central counterparty clearing providers.

CME Group generates revenue mainly from trading and clearing fees, market data subscriptions, and licensing of benchmark indices. Trading and clearing fees arise from futures options cash and over the counter contracts executed on its exchanges and cleared through its clearing house. Market data revenue comes from real time historical and derived data products distributed to traders institutions and data vendors. Licensing revenue includes fees for the use of CME Term SOFR and other benchmark rates administered by its subsidiary.

The company operates through the following segments: Derivatives Exchange, Derivatives Clearing, Securities Clearing, Cash Markets, and Data Services.

• Derivatives Exchange: This segment offers futures options cash and over the counter contracts across interest rate equity index foreign exchange agricultural energy metals and cryptocurrency markets. It provides trading through the CME Globex electronic platform open outcry in Chicago and privately negotiated transactions.

• Derivatives Clearing: This segment provides clearing and settlement services for exchange traded futures options swaps and over the counter derivatives. It operates the CME ClearPort front end system and offers margin services collateral optimization and risk management tools.

• Securities Clearing: This segment consists of CME Securities Clearing Inc which is preparing to launch clearing services for U S Treasury and repo transactions to meet upcoming regulatory requirements.

• Cash Markets: This segment comprises BrokerTec and EBS which deliver electronic trading for fixed income and foreign exchange products. BrokerTec focuses on government bonds repos and supranational securities while EBS provides spot foreign exchange and spot precious metals trading.

• Data Services: This segment supplies real time historical and derived market data analytic tools and benchmark indices. It distributes data via its own platforms and third party partners and licenses benchmarks such as CME Term SOFR and CME Term EUR STR rates.

CME Group holds a leading position in the global derivatives marketplace due to its deep liquidity broad product range and efficient clearing services. Its main competitors include Intercontinental Exchange Cboe Global Markets Euronext Hong Kong Exchanges and Clearing and Deutsche Börse. The company differentiates itself through technological innovation high frequency trading infrastructure strong risk management solutions and a global distribution network.

CME Group serves professional traders financial institutions institutional and individual investors corporations producers governments and central banks. Its customers range from large banks and hedge funds to individual retail traders accessing the market through brokers.

Investment Thesis

▲ Bull case

CME Group's Q1 2026 financial performance demonstrates exceptional momentum that the market may be underestimating, particularly in revenue and volume growth across all asset classes. The company reported a record $1.9 billion in revenue for Q1 2026, a 14% year-over-year increase, driven by a 22% surge in average daily volume (ADV) to 36.2 million contracts—the highest quarterly ADV ever recorded. This growth was broad-based, with record ADV in every asset class and non-U.S. ADV rising 30% to 11.4 million contracts, led by APAC (up 33%) and EMEA (up 29%). The strength in international markets reflects deepening global participation, especially in commodities, where EMEA volume grew 34% in 2024 and remains a key growth engine. This international expansion is not merely a temporary tailwind but a structural shift, as CME continues to tailor products like micro agriculture contracts for APAC retail investors and leverages its diversified offering to capture cross-border hedging demand amid persistent geopolitical and macroeconomic volatility. The market may be overlooking how this international footprint creates a durable, diversified revenue base less reliant on U.S.-centric cycles.
CME's strategic product innovation in high-growth niches—particularly in cryptocurrency and compute futures—represents an underappreciated catalyst for long-term revenue diversification and margin expansion. The launch of 24/7 trading for cryptocurrency futures and options on May 29, 2026, directly addresses the 24/7 nature of crypto markets, unlocking new liquidity and institutional participation, as evidenced by over 7,200 contracts traded (~$50 million notional) in the inaugural weekend. Furthermore, the planned June 8 launch of Nasdaq CME Crypto Index futures—a first-of-its-kind market-cap weighted product—will provide capital-efficient exposure to top cryptocurrencies via a single contract, tapping into growing demand for regulated, broad-based crypto risk management tools. Beyond crypto, the partnership with Silicon Data to launch compute futures later in 2026 targets the multi-trillion-dollar GPU and AI infrastructure market, positioning CME at the forefront of an emerging asset class where demand for volatility and price risk hedging is accelerating. These initiatives are not incremental but transformative, expanding CME's total addressable market into fast-growing, digitally driven sectors where its regulated exchange model offers a distinct competitive advantage over unregulated venues.
The company's capital return framework and balance sheet strength provide a powerful, underdiscussed buffer against volatility while enhancing shareholder value through disciplined, flexible deployment. CME returned $3.8 billion in dividends during 2024, including a $2.1 billion variable dividend paid in January 2025, and raised its quarterly dividend from $1.15 to $1.25. Concurrently, it authorized a $3 billion opportunistic share repurchase program, with $536 million already executed in Q1 2026. This capital allocation strategy—prioritizing dividends while maintaining buyback flexibility—reflects strong free cash flow generation, supported by $3.4 billion in cash and marketable securities as of March 31, 2026, despite $3.4 billion in debt. The adjusted operating margin expanded to 68.3% in 2024, up over 140 basis points, and Q1 2026 adjusted operating income reached $1.37 billion, up 17% year-over-year. This profitability, combined with a conservative approach to M&A and a focus on core competencies in risk management and capital efficiency, allows CME to navigate regulatory or macroeconomic headwinds without compromising growth investments. The market may be underestimating how this financial resilience enables sustained reinvestment in growth initiatives like cloud migration ($115 million guided for 2025) and product innovation, even amid uncertain conditions.

CME Group's Q1 2026 financial performance demonstrates exceptional momentum that the market may be underestimating, particularly in revenue and volume growth across all asset classes. The company reported a record $1.9 billion in revenue for Q1 2026, a 14% year-over-year increase, driven by a 22% surge in average daily volume (ADV) to 36.2 million contracts—the highest quarterly ADV ever recorded. This growth was broad-based, with record ADV in every asset class and non-U.S. ADV rising 30% to 11.4 million contracts, led by APAC (up 33%) and EMEA (up 29%). The strength in international markets reflects deepening global participation, especially in commodities, where EMEA volume grew 34% in 2024 and remains a key growth engine. This international expansion is not merely a temporary tailwind but a structural shift, as CME continues to tailor products like micro agriculture contracts for APAC retail investors and leverages its diversified offering to capture cross-border hedging demand amid persistent geopolitical and macroeconomic volatility. The market may be overlooking how this international footprint creates a durable, diversified revenue base less reliant on U.S.-centric cycles.
CME's strategic product innovation in high-growth niches—particularly in cryptocurrency and compute futures—represents an underappreciated catalyst for long-term revenue diversification and margin expansion. The launch of 24/7 trading for cryptocurrency futures and options on May 29, 2026, directly addresses the 24/7 nature of crypto markets, unlocking new liquidity and institutional participation, as evidenced by over 7,200 contracts traded (~$50 million notional) in the inaugural weekend. Furthermore, the planned June 8 launch of Nasdaq CME Crypto Index futures—a first-of-its-kind market-cap weighted product—will provide capital-efficient exposure to top cryptocurrencies via a single contract, tapping into growing demand for regulated, broad-based crypto risk management tools. Beyond crypto, the partnership with Silicon Data to launch compute futures later in 2026 targets the multi-trillion-dollar GPU and AI infrastructure market, positioning CME at the forefront of an emerging asset class where demand for volatility and price risk hedging is accelerating. These initiatives are not incremental but transformative, expanding CME's total addressable market into fast-growing, digitally driven sectors where its regulated exchange model offers a distinct competitive advantage over unregulated venues.
The company's capital return framework and balance sheet strength provide a powerful, underdiscussed buffer against volatility while enhancing shareholder value through disciplined, flexible deployment. CME returned $3.8 billion in dividends during 2024, including a $2.1 billion variable dividend paid in January 2025, and raised its quarterly dividend from $1.15 to $1.25. Concurrently, it authorized a $3 billion opportunistic share repurchase program, with $536 million already executed in Q1 2026. This capital allocation strategy—prioritizing dividends while maintaining buyback flexibility—reflects strong free cash flow generation, supported by $3.4 billion in cash and marketable securities as of March 31, 2026, despite $3.4 billion in debt. The adjusted operating margin expanded to 68.3% in 2024, up over 140 basis points, and Q1 2026 adjusted operating income reached $1.37 billion, up 17% year-over-year. This profitability, combined with a conservative approach to M&A and a focus on core competencies in risk management and capital efficiency, allows CME to navigate regulatory or macroeconomic headwinds without compromising growth investments. The market may be underestimating how this financial resilience enables sustained reinvestment in growth initiatives like cloud migration ($115 million guided for 2025) and product innovation, even amid uncertain conditions.

▼ Bear case

CME's reliance on fee-based revenue growth through transaction and clearing fee adjustments masks potential volume sensitivity and competitive pressures that the market may be ignoring. While management guided that transaction fee adjustments effective February 1, 2026, would add 1%-1.5% to futures and options revenue under stable trading patterns, and the 10-basis-point non-cash collateral surcharge (effective April) could add another 1%-1.5% to pre-tax income, these assumptions depend heavily on customer behavior and stable volumes. The Q1 2026 average rate per contract (RPC) declined to $0.652 from $0.686 in Q1 2025—a 5% drop—reflecting a mix shift toward lower-RPC products like interest rates and energy, despite higher volumes. This highlights the risk that volume growth may come from lower-margin products or customer segments, diluting RPC and offsetting fee increases. Furthermore, the collateral surcharge's impact is contingent on clients not shifting to cash posting; if they increase cash collateral to avoid the fee, the expected 2%-2.5% pre-tax income boost may not materialize. The market may be overestimating the predictability of these fee-driven tailwinds without considering how pricing elasticity, tiered volume discounts, or shift to lower-fee venues (e.g., open outcry or privately negotiated) could erode pricing power.
The company's aggressive investment in cloud migration and data services introduces execution risk and potential margin pressure that may be underappreciated, particularly as benefits remain long-term and costs are front-loaded. CME guided for approximately $115 million in cloud migration expenses in 2025, up from $85 million in 2024, aimed at migrating non-latency sensitive applications and expanding data services. While this investment is framed as enabling future scalability and client data analytics, it contributes directly to adjusted operating expenses, which are guided to rise to approximately $1.65 billion in 2025 from $1.59 billion in 2024. The migration involves significant professional services and technology spend, with Q4 2024 alone seeing $22 million in cloud-related costs. Despite the strategic rationale, there is no clear timeline for when these investments will translate into measurable revenue growth or cost savings, and the company continues to rely on legacy systems during the transition. The market may be assuming a smooth, timely migration with rapid ROI, but any delays, cost overruns, or failure to monetize enhanced data services could weigh on margins, especially if volume growth slows or fee increases fail to offset rising OPEX.
CME's expanding product suite in volatile, nascent asset classes like cryptocurrency and compute futures carries regulatory and adoption uncertainty that could constrain growth expectations, despite management's optimistic framing. The launch of Bitcoin Volatility futures on June 1, 2026, and the planned Nasdaq CME Crypto Index futures on June 8, 2026, are explicitly pending regulatory review, with management acknowledging they will not "front-run" the SEC on additional crypto products beyond Bitcoin and Ether until clarity emerges. Similarly, the compute futures partnership with Silicon Data is subject to pending regulatory review, introducing uncertainty around timing and scope. While cryptocurrency ADV showed strength—February 2026 saw nearly 700,000 contracts in a single day—the asset class remains inherently volatile and sensitive to regulatory shifts, as evidenced by the cautious approach to altcoin derivatives. The compute futures concept, while innovative, targets a highly fragmented GPU pricing market with no established benchmark, and success depends on adoption by AI builders, cloud providers, and financial institutions who may prefer bilateral agreements or other venues. The market may be pricing in aggressive growth from these initiatives without sufficient regard for regulatory hurdles, slow institutional adoption, or the possibility that demand fails to materialize at scale, leaving CME with sunk costs in products that struggle to gain traction.

CME's reliance on fee-based revenue growth through transaction and clearing fee adjustments masks potential volume sensitivity and competitive pressures that the market may be ignoring. While management guided that transaction fee adjustments effective February 1, 2026, would add 1%-1.5% to futures and options revenue under stable trading patterns, and the 10-basis-point non-cash collateral surcharge (effective April) could add another 1%-1.5% to pre-tax income, these assumptions depend heavily on customer behavior and stable volumes. The Q1 2026 average rate per contract (RPC) declined to $0.652 from $0.686 in Q1 2025—a 5% drop—reflecting a mix shift toward lower-RPC products like interest rates and energy, despite higher volumes. This highlights the risk that volume growth may come from lower-margin products or customer segments, diluting RPC and offsetting fee increases. Furthermore, the collateral surcharge's impact is contingent on clients not shifting to cash posting; if they increase cash collateral to avoid the fee, the expected 2%-2.5% pre-tax income boost may not materialize. The market may be overestimating the predictability of these fee-driven tailwinds without considering how pricing elasticity, tiered volume discounts, or shift to lower-fee venues (e.g., open outcry or privately negotiated) could erode pricing power.
The company's aggressive investment in cloud migration and data services introduces execution risk and potential margin pressure that may be underappreciated, particularly as benefits remain long-term and costs are front-loaded. CME guided for approximately $115 million in cloud migration expenses in 2025, up from $85 million in 2024, aimed at migrating non-latency sensitive applications and expanding data services. While this investment is framed as enabling future scalability and client data analytics, it contributes directly to adjusted operating expenses, which are guided to rise to approximately $1.65 billion in 2025 from $1.59 billion in 2024. The migration involves significant professional services and technology spend, with Q4 2024 alone seeing $22 million in cloud-related costs. Despite the strategic rationale, there is no clear timeline for when these investments will translate into measurable revenue growth or cost savings, and the company continues to rely on legacy systems during the transition. The market may be assuming a smooth, timely migration with rapid ROI, but any delays, cost overruns, or failure to monetize enhanced data services could weigh on margins, especially if volume growth slows or fee increases fail to offset rising OPEX.
CME's expanding product suite in volatile, nascent asset classes like cryptocurrency and compute futures carries regulatory and adoption uncertainty that could constrain growth expectations, despite management's optimistic framing. The launch of Bitcoin Volatility futures on June 1, 2026, and the planned Nasdaq CME Crypto Index futures on June 8, 2026, are explicitly pending regulatory review, with management acknowledging they will not "front-run" the SEC on additional crypto products beyond Bitcoin and Ether until clarity emerges. Similarly, the compute futures partnership with Silicon Data is subject to pending regulatory review, introducing uncertainty around timing and scope. While cryptocurrency ADV showed strength—February 2026 saw nearly 700,000 contracts in a single day—the asset class remains inherently volatile and sensitive to regulatory shifts, as evidenced by the cautious approach to altcoin derivatives. The compute futures concept, while innovative, targets a highly fragmented GPU pricing market with no established benchmark, and success depends on adoption by AI builders, cloud providers, and financial institutions who may prefer bilateral agreements or other venues. The market may be pricing in aggressive growth from these initiatives without sufficient regard for regulatory hurdles, slow institutional adoption, or the possibility that demand fails to materialize at scale, leaving CME with sunk costs in products that struggle to gain traction.

Peer Comparison

Companies in the Financial Data & Stock Exchanges

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	BTOG	BIT ORIGIN Ltd	1,110.84 Bn	-	-	-
2	SPGI	S&P Global Inc.	130.72 Bn	25.37	8.31	13.32 Bn
3	CME	Cme Group Inc.	92.16 Bn	21.56	13.61	3.42 Bn
4	MCO	Moodys Corp /De/	84.72 Bn	30.28	10.38	7.52 Bn
5	ICE	Intercontinental Exchange, Inc.	84.12 Bn	21.08	9.26	20.37 Bn
6	NDAQ	Nasdaq, Inc.	53.10 Bn	26.99	6.07	8.76 Bn
7	COIN	Coinbase Global, Inc.	44.25 Bn	55.27	6.75	7.76 Bn
8	MSCI	MSCI Inc.	41.65 Bn	30.67	12.49	6.38 Bn

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password